Rockwell Medical, Inc. (DE) Common Stock (RMTI) is a publicly traded Healthcare sector company. As of May 21, 2026, RMTI trades at $0.79 with a market cap of $30.84M and a P/E ratio of -5.45. RMTI moved +2.23% today. Year to date, RMTI is -17.00%; over the trailing twelve months it is -23.36%. Its 52-week range spans $0.74 to $5.15. Analyst consensus is buy with an average price target of $3.00. Rallies surfaces RMTI's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Hedge funds tracked by Rallies that own RMTI include Panagora Asset. The latest tracked quarter is Mar 31, 2026. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Rockwell Medical, Inc. (DE) Common Stock.
| Metric | Value |
|---|---|
| Price | $0.79 |
| Market Cap | $30.84M |
| P/E Ratio | -5.45 |
| EPS | $-0.15 |
| Dividend Yield | 0.00% |
| 52-Week High | $5.15 |
| 52-Week Low | $0.74 |
| Volume | 9.71K |
| Avg Volume | 0 |
| Revenue (TTM) | $67.68M |
| Net Income | $-5.40M |
| Gross Margin | 17.07% |
2 analysts cover RMTI: 0 strong buy, 2 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $3.00.